https://www.avient.com/sites/default/files/2022-07/Avient Announces Second Quarter 2022 Results_1.pdf
AVNT-2022.06.30-News Release
1
NEWS RELEASE
FOR IMMEDIATE RELEASE
Avient Announces Second Quarter 2022 Results
• Second quarter sales grew to $1.3 billion, a 5% increase over the prior year quarter, and
an all-time quarterly record
• GAAP EPS increased 24% to $0.92 compared to $0.74 in the prior year quarter
• Adjusted EPS increased 13% to $0.98 compared to $0.87 in the prior year quarter,
exceeding second quarter guidance of $0.92.
https://www.avient.com/sustainability
https://www.avient.com/investors
https://edge.media-server.com/mmc/p/r2x4n7pt
https://www.avient.com/investors
https://register.vevent.com/register/BIb9438661fe984c4f9a842829169d2868
http://www.avient.com/investors/events-presentations
3
About Avient
Avient Corporation (NYSE: AVNT), with 2021 revenues of $4.8 billion, provides specialized and
sustainable material solutions that transform customer challenges into opportunities, bringing
new products to life for a better world.
# #
Investor Relations Contact:
Giuseppe (Joe) Di Salvo
Vice President, Treasurer and Investor Relations
Avient Corporation
+1 440-930-1921
giuseppe.disalvo@avient.com
Media Contact:
Kyle G.
https://www.avient.com/sites/default/files/2021-07/avient-human-rights-position-statement-updated-july-2021.pdf
Avient Corporation
33587 Walker Road
Avon Lake, OH 44012
1
AVIENT’S POSITION ON HUMAN RIGHTS
July 2021
OUR COMMITMENT
Avient is dedicated to conducting business ethically and with integrity, and our Position on Human Rights
is part of our commitment to socially responsible business practices.
Our
disclosures are located at:
https://www.avient.com/company/policies-and-governance/ca-transparency-act-disclosure
https://www.avient.com/company/policies-and-governance/europe-modern-slavery-and-human-trafficking-
statement
We reinforce Our Commitment to human rights, as set forth above, throughout our organization by
incorporating and reflecting these principles in organizational policies, training programs, and our
governance management framework.
https://www.avient.com/company/policies-and-governance/ca-transparency-act-disclosure
https://www.avient.com/company/policies-and-governance/europe-modern-slavery-and-human-trafficking-statement
https://www.avient.com/company/policies-and-governance/europe-modern-slavery-and-human-trafficking-statement
https://www.avient.com/sites/default/files/2020-10/supplier-code-of-conduct.pdf
https://www.avient.com/sites/default/files/2021-05/avnt-tpe-beginner-guide-fin.pdf
To help you identify
the right materials for your product, they will need to know:
1. the kind of environment in which your product will be used
2. what kind of properties you need (e.g., stretchy, hard or soft, color)
Is TPE the best material for my products?
https://www.avient.com/idea-filter?
productgroup=85&theme=
https://www.avient.com/idea-filter?
https://www.avient.com/sites/default/files/resources/PolyOne%2520Standard%2520Quality%2520Response_2016_6_9.pdf
Avon Lake, OH 44012
P: +1 (440) 930-3000
I: +1 (866) 737-2066
F: +1 (440) 930-3064
Dear Valued Customer:
Thank you for your inquiry regarding the quality system at PolyOne.
Yes.
5.2 Supplier Management
1.
1 to 21 days based on the specific product
and/or process.
3.
https://www.avient.com/sites/default/files/2024-06/CM Europe Ltd Modern_Slavery_Statement - 2024 V4.pdf
Modern Slavery Template Statement (HEPA)
Page 1 of 3
ColorMatrix Europe Limited - Modern Slavery and Human Trafficking Statement
This statement has been published in accordance with section 54(1) of the Modern Slavery Act 2015 and constitutes the
modern slavery and human trafficking statement of ColorMatrix Europe Limited (“ColorMatrix”) and covers the 2023
financial year.
A full copy of Avient’s Code of Conduct is available in over 20 languages and can be found here:
Avient’s Position on Human Rights can be found here
http://www.avient.com/
https://www.avient.com/company/policies-and-governance-0/code-conduct
https://www.avient.com/sites/default/files/2021-07/avient-human-rights-position-statement-updated-july-2021.pdf
Page 2 of 3
Training
To mitigate against the risk of non-compliance with our policy, Avient requires all associates to complete mandatory Code of Conduct
training.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Seaport%2520Global%2520Transports%2520%2526%2520Industrials%2520Conference.pdf
Addressable market exceeds $40 billion
Strong performance demonstrates that our strategy and execution
are working
Megatrends and emerging opportunities align with strengths
Innovation and services provide differentiation, incremental pricing
power and competitive advantage
Strategic balance between reinvestment for growth and returning
cash to shareholders
Strong and proven management team driving growth and
performance
18 POLYONE CORPORATION
Segment Highlights
POLYONE CORPORATION 19
2016 Revenue: $0.8 Billion
At a Glance: Color, Additives & Inks
Key Applications
2016 Revenue by Industry Expanding Profits
1.7%
4.6% 5.1% 5.5%
7.2% 8.1%
9.7%
12.2%
14.7%
16.7% 16.0%
20%+
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2020
Operating Income % of Sales
Platinum
Vision
United
States
45%
Europe
33%
Asia
15% Latin
America
5%
Canada
2%
Packaging
30%
Industrial
15%
W & C
10%
B & C
10% Textiles
9%
Transportation
9%
Consumer
7%
Healthcare
6%
Appliance
2%
E & E
2%
POLYONE CORPORATION 20
2016 Revenue: $0.6 Billion
At a Glance: Specialty Engineered Materials
2016 Revenue by Industry Expanding Profits
1.1% 1.3%
3.4%
5.1%
9.6%
8.0% 8.6% 9.3%
12.1%
14.7% 14.3%
20%+
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2020
Operating Income % of Sales
Platinum
Vision
Consumer
19% Transportation
19%
E & E
15%
W & C
15%
Healthcare
11%
Industrial
8%
Packaging
7%
Appliance
3%
B & C
3%
United
States
51%
Europe
27%
Asia
20%
Canada
2%
Key Applications
POLYONE CORPORATION 21
2016 Revenue: $0.4 Billion
At a Glance: Designed Structures & Solutions
2016 Revenue by Industry Expanding Profits
1.4%
5.6%
7.3%
3.0%
8-10%
-0.9%
2012 2013 2014 2015 2016 2020
Operating Income % of Sales
Platinum
Vision
Transportation
27%
Industrial
21%
Packaging
21%
B & C
11% Healthcare
8%
Consumer
8%
Appliance
3%
E & E
1%
Key Applications
United
States
95%
Canada
5%
http://www.google.com/url?
sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAcQjRw&url=http://www.mullerquaker.com/products/greek100/greek100-peach-and-passion-fruit&ei=-acYVZq7EIqwyASDjYL4CA&bvm=bv.89381419,d.cWc&psig=AFQjCNGNCQY1_dCN2RPLzxtap_Pu0omTXQ&ust=1427765484498432
POLYONE CORPORATION 22
2016 Revenue: $0.7 Billion
At a Glance: Performance Products & Solutions
2016 Revenue by Industry Expanding Profits
5.5%
6.9%
3.8% 3.6%
5.5%
4.3%
6.3% 7.2% 7.7%
8.3%
12-14%
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2020
Operating Income % of Sales
Platinum
Vision
11.1%
B & C
30%
Transportation
18%
W & C
16%
Industrial
16% Appliance
6%
Consumer
5%
Packaging
5%
E & E
3%
Healthcare
1%
United
States
78%
Canada
16%
Latin
America
4%
Asia
2%
Key Applications
POLYONE CORPORATION 23
2016 Revenue: $1.1 Billion
At a Glance: Distribution
Key Suppliers
ROIC Expanding Profits
2.6%
3.0%
3.5%
4.0%
4.6%
5.6%
6.4%
5.9% 6.1%
6.6%
6.5-7.5%
6.4%
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2020
Operating Income % of Sales
Platinum
Vision
15%
51%
2006 2016
Transportation
24%
Healthcare
22%
Industrial
18%
Consumer
15% Appliance
6%
E & E
5%
B & C
4%
Packaging
4%
W & C
2%
http://www.avient.com/Pages/VariationRoot.aspx
24 POLYONE CORPORATION
Application Examples
POLYONE CORPORATION 25
Luxury Packaging
with Gravitech Density Modified Polymers
Impart weight, sound and
metallic finish to caps and
closures for cosmetics and
spirits applications
Elevate quality and prestige
perceptions among high-end
consumers
Eliminate time and cost
associated with secondary
operations and assembly
POLYONE CORPORATION 26
Eliminate costs by increasing
pigment density
Enhance color performance
without altering form and
formulation
Increase design capabilities by
reducing weight and layer
thickness
Optimize Color Usage
with OnColor Super Concentrates
POLYONE CORPORATION 27
Inhibit microbial growth on
polymer surface
Enhance value or products
and devices
Highly versatile concentrate
with the ability to be
incorporated into a wide
variety of products
Combat Bacteria Formation
with WithStand Antimicrobial Technology
POLYONE CORPORATION 28
Medical Device Housings
with Chemically Resistant Engineered Polymers
Durable, long-lasting
products stand up to the
most aggressive disinfectants
Minimize environmental
stress cracking and
discoloration
One of the broadest
medically approved polymer
and colorant portfolios
POLYONE CORPORATION 29
Color & Design Services
Greater control of color development
and supply chain
Work across entire design process
from concept to commercialization
Inspire creativity in the use of
polymer materials, colors
and effects
Innovative brand differentiation
Faster development timelines
POLYONE CORPORATION 30
Outdoor Applications
Leading provider of high performance
specialty materials for the recreational
and sports & leisure industry
Well positioned across all segments to
address market needs
Metal to Polymer Conversion
Lightweighting
Thermal Management
Impact Performance
Source: Outdoor Industry Association
POLYONE CORPORATION 31
Fiber Colorants
Solutions for clothing, apparel, footwear, automotive & sporting goods
ColorMatrix Fiber Colorant Solutions
Proprietary advanced liquid color
formulations and equipment enable
greater efficiency and productivity
Eliminates aqueous dyeing and its
associated wastewater treatment
Solid Color Concentrates
Extrusion-spun fibers colored via
solid masterbatch
POLYONE CORPORATION 32
High-Barrier Packaging Containers
Capability to extrude up to 13
layers
Strong oxygen and moisture vapor
transmission protection
Can be made symmetrical or
asymmetrical to meet customized
needs of broad variety of
applications
Barrier protection and superior
sensory properties
1
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Senior management uses comparisons of adjusted net income attributable to PolyOne common shareholders, adjusted earnings per share (EPS) attributable to PolyOne common
shareholders and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in
understanding current profitability levels and that current levels may serve as a base for future performance.
Adjusted EPS attributable to PolyOne common shareholders is calculated as follows:
2009* 2010 2011 2012 2013 2014 2015 2016
Net income attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 165.2
Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — —
Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 35.5
Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (20.7)
Adjusted net income attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 180.0
Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6
Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.13
Adjusted operating income is calculated as follows:
2006* 2016
Operating income $ 233.6 $ 281.9
Special items (1) (39.1) 35.3
Joint venture equity earnings (107.0) 0.0
Adjusted operating income $ 87.5 $ 317.2
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation
https://www.avient.com/sites/default/files/2020-10/auto-injector-application-study.pdf
Autoinjector Pen - Avient Application Study.mm (1)
AUTO-INJECTOR
APPLICATION STUDY
M A T E R I A L T E C H N O L O G I E S +
S E R V I C E S F O R N E X T
G E N E R A T I O N D E S I G N S
Avient Corporation 1
Avient Corporation 2
Innovating Design
Medical innovations and plastics have gone
hand-in-hand to make healthcare safer, cleaner,
and more accessible for all.
We can help tackle your toughest
challenges with our
• In-depth industry knowledge
• Expansive material solutions
• Far-reaching technical capabilities
and services
Avient Corporation 4
1
Injection window
Integrated rigid
needle shield
2
Cap
3
1.
Requirements:
USP Class VI skin contact
colorant for drug differentiation
OnColor™ HC, MEVOPUR® 4
Button
5
Batch or SKU
identifier
Safety and
trigger cap
6
CONCENTRATION 1
CONCENTRATION 2
CONCENTRATION 3
Patient Handling
Age or certain disease states can
severely limit patient dexterity making
the self-administration of
medication difficult and frustrating.
https://www.avient.com/sites/default/files/2024-06/Smartbatch-PE Tarpaulin-Case study snapshot.pdf
https://www.avient.com/products/polymer-colorants/color-additive-combination-masterbatches/smartbatch-combination-colorants-additives
Slide 1: PE Tarpaulin manufacturer
https://www.avient.com/sites/default/files/2022-10/Omnicolor Case Study Plastic Molder.pdf
PLASTIC INJECTION
MOLDER
V A R I O U S M A R K E T S &
A P P L I C A T I O N S
• Ability to use a color concentrate in multiple resins
• Low let down ratio (LDR)
• Color consistency over time
• Offered versatile solution across resins and
in various molding methods
• Provided range of 1-3% LDRs in four
standard colors
• Achieved consistent color in a variety of
products and markets for over 10 years
Omnicolor™ Multipurpose Colorants
KEY REQUIREMENTS
WHY AVIENT?
AVIENT SOLUTION
MULTIPLE RESIN USE + LOW LDR
LEARN MORE© 2022, Avient Corporation, All Rights Reserved
https://www.avient.com/products/polymer-colorants/solid-color-masterbatches/omnicolor-multipurpose-masterbatches
https://www.avient.com/sites/default/files/2024-09/OnFlex-Lip gloss tube tip -case study snapshot_0904.pdf
https://www.avient.com/products/thermoplastic-elastomers/onflex-thermoplastic-elastomers
Slide 1: Cosmetic packaging manufacturer